BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38631221)

  • 1. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
    Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
    Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
    Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R
    Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta-analysis.
    Feng Y; Wang J; Tan D; Cheng P; Wu A
    Cancer Med; 2019 Dec; 8(17):7454-7468. PubMed ID: 31599129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
    Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
    Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
    Fellhofer-Hofer J; Franz C; Vey JA; Kahlert C; Kalkum E; Mehrabi A; Halama N; Probst P; Klupp F
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the new CXCL12 receptor, CXCR7, in gliomas.
    Calatozzolo C; Canazza A; Pollo B; Di Pierro E; Ciusani E; Maderna E; Salce E; Sponza V; Frigerio S; Di Meco F; Schinelli S; Salmaggi A
    Cancer Biol Ther; 2011 Jan; 11(2):242-53. PubMed ID: 21084856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.
    Groblewska M; Litman-Zawadzka A; Mroczko B
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
    Qiu L; Xu Y; Xu H; Yu B
    BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
    Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
    Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
    Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
    Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
    Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
    Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
    Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
    Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.
    Kong X; Guan J; Ma W; Li Y; Xing B; Yang Y; Wang Y; Gao J; Wei J; Yao Y; Xu Z; Dou W; Lian W; Su C; Ren Z; Wang R
    Medicine (Baltimore); 2016 Feb; 95(7):e2830. PubMed ID: 26886640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.
    Wang DP; Kang K; Lin Q; Hai J
    Clin Transl Sci; 2020 Jan; 13(1):179-188. PubMed ID: 31550075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
    Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
    PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
    Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
    Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
    Lu VM; Alvi MA; McDonald KL; Daniels DJ
    J Neurosurg Pediatr; 2018 Nov; 23(3):308-316. PubMed ID: 30544362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.